Leaderboards/Fungal Infections and Studies

Fungal Infections and Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Diana M. Proctor
The University of Texas MD Anderson Cancer Center
2
Darian J. Santana
St. Jude Children's Research Hospital
3
Maria Siopi
National and Kapodistrian University of Athens
4
Christopher Prestel
Centers for Disease Control and Prevention
5
Michael J. Boucher
University of California, San Francisco
6
Mark V. Horton
University of Wisconsin–Madison
7
Danilo Yamamoto Thomaz
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
8
Elizabeth Misas
Oak Ridge Associated Universities
9
Amanda Ribeiro dos Santos
Universidade de São Paulo
10
Rohan S. Wakade
University of Iowa

Papers

1
Publication in The Lancet Microbe (2024) [32 citations, W4392304100]
The Lancet Microbe|2024
32 cit.
2
Evaluation of the Vitek 2 system for antifungal susceptibility testing of <i>Candida auris</i> using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance
Journal of Clinical Microbiology|2024
32 cit.
3
Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023
Eurosurveillance|2024
29 cit.
4
Clonal Candida auris and ESKAPE pathogens on the skin of residents of nursing homes
Nature|2025
28 cit.
5
Publication in Open Forum Infectious Diseases (2024) [20 citations, W4396661470]
Open Forum Infectious Diseases|2024
20 cit.
6
Publication in Journal of Clinical Microbiology (2024) [17 citations, W4391169048]
Journal of Clinical Microbiology|2024
17 cit.
7
Publication in mSphere (2024) [17 citations, W4391434672]
mSphere|2024
17 cit.
8
Publication in Mycoses (2025) [14 citations, W4413116621]
Mycoses|2025
14 cit.
9
Publication in Antimicrobial Agents and Chemotherapy (2024) [13 citations, W4392044826]
Antimicrobial Agents and Chemotherapy|2024
13 cit.
10
Publication in mSphere (2024) [10 citations, W4391966064]
mSphere|2024
10 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Jeniel E. Nett
University of Wisconsin–Madison
2
Anna Selmecki
UCLA Medical Center
3
Andrej Spec
Washington University in St. Louis
4
Fausto Almeida
Universidade de Ribeirão Preto
5
Silke Uhrlaß
Marienhospital Bottrop
6
Weihua Pan
Naval Medical Research Command
7
Frédéric Lamoth
Czech Academy of Sciences, Institute of Microbiology
8
Philipp Koehler
University Hospital Cologne
9
Linqi Wang
Chinese Academy of Sciences
10
Talya Finn
Laniado Hospital

Papers

1
Pulmonary aspergillosis: diagnosis and treatment
European Respiratory Review|2022
131 cit.
2
The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era
Clinical Infectious Diseases|2022
112 cit.
3
Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study
Journal of Infection|2024
106 cit.
4
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective
Clinical Infectious Diseases|2022
77 cit.
5
Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance <i>In Vitro</i> and <i>In Vivo</i>
mBio|2022
76 cit.
6
Mechanisms of pathogenicity for the emerging fungus Candida auris
PLoS Pathogens|2023
65 cit.
7
Fungal Extracellular Vesicles Are Involved in Intraspecies Intracellular Communication
mBio|2022
64 cit.
8
Attributable Mortality of <i>Candida</i> Bloodstream Infections in the Modern Era: A Propensity Score Analysis
Clinical Infectious Diseases|2022
63 cit.
9
Pan-drug resistance and hypervirulence in a human fungal pathogen are enabled by mutagenesis induced by mammalian body temperature
Nature Microbiology|2024
57 cit.
10
Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris
Antimicrobial Agents and Chemotherapy|2022
55 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Arturo Casadevall
Johns Hopkins University
2
Joseph Heitman
Duke University
3
David A. Stevens
Stanford University
4
Thomas J. Walsh
Cornell University
5
John E. Bennett
National Institute of Allergy and Infectious Diseases
6
Dimitrios P. Kontoyiannis
The University of Texas MD Anderson Cancer Center
7
Thomas F. Patterson
National Institute of Allergy and Infectious Diseases
8
David W. Denning
Manchester Academic Health Science Centre
9
David R. Boulware
University of Minnesota Medical Center
10
Bernhard Hube
Czech Academy of Sciences, Institute of Microbiology

Papers

1
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Clinical Infectious Diseases|2008
4.9k cit.
2
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2016
2.8k cit.
3
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Clinical Infectious Diseases|2008
2.7k cit.
4
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Clinical Infectious Diseases|2002
2.3k cit.
5
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Science|1991
2k cit.
6
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
The Lancet Infectious Diseases|2017
1.9k cit.
7
High Capacity Anode Materials for Rechargeable Sodium-Ion Batteries
Journal of The Electrochemical Society|2000
1.8k cit.
8
The Mechanisms of Lithium and Sodium Insertion in Carbon Materials
Journal of The Electrochemical Society|2001
1.5k cit.
9
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
Clinical Infectious Diseases|2010
1.4k cit.
10
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus
Nature|2005
1.4k cit.

Reagents for Fungal Infections and Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling TechnologyEvidence 67

BiP (C50B12) Rabbit Monoclonal Antibody (PE Conjugate)

#14464$465
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Phospho-Akt (Ser473) (D9E) Rabbit Monoclonal Antibody (Alexa Fluor® 532 Conjugate)

#26580$493
View Evidence →
Cell Signaling Technology

ADAP Antibody

#11957$317
View Evidence →
Cell Signaling TechnologyEvidence 66

eIF2 alpha (D7D3) Rabbit Monoclonal Antibody (Biotinylated)

#9079$556
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

CUL1 Antibody

Cited in 5 papers
#4995$317
View Evidence →
Cell Signaling TechnologyEvidence 65

Akt1 (C73H10) Rabbit Monoclonal Antibody

#2938$148,348
View Evidence →
Millipore

Anti-BACE Proteins Anti-BACE Proteins Investigator minipack , Unconjugated

#15-206
View Evidence →